The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) that veterinarians prescribe as a supportive treatment for various conditions in animals. It provides day-to-day treatment for pain and inflammation from various kinds of joint pain as well as post-operative pain.
Global Carprofen market is projected to reach US$ 97.2 million in 2029, increasing from US$ 73 million in 2022, with the CAGR of 3.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Carprofen market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Carprofen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Zoetis
Chanelle Pharma
AVENTIX
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
ElancoDVM
Vethical
Vetoquinol
Pivetal
Segment by Type
Ibuprofen
Naproxen
Ketoprofen
Segment by Application
Dog
Cat
Horse
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Carprofen report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) that veterinarians prescribe as a supportive treatment for various conditions in animals. It provides day-to-day treatment for pain and inflammation from various kinds of joint pain as well as post-operative pain.
Global Carprofen market is projected to reach US$ 97.2 million in 2029, increasing from US$ 73 million in 2022, with the CAGR of 3.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Carprofen market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Carprofen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Zoetis
Chanelle Pharma
AVENTIX
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
ElancoDVM
Vethical
Vetoquinol
Pivetal
Segment by Type
Ibuprofen
Naproxen
Ketoprofen
Segment by Application
Dog
Cat
Horse
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Carprofen report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Carprofen Market Overview
1.1 Product Overview and Scope of Carprofen
1.2 Carprofen Segment by Type
1.2.1 Global Carprofen Market Value Comparison by Type (2023-2029)
1.2.2 Ibuprofen
1.2.3 Naproxen
1.2.4 Ketoprofen
1.3 Carprofen Segment by Application
1.3.1 Global Carprofen Market Value by Application: (2023-2029)
1.3.2 Dog
1.3.3 Cat
1.3.4 Horse
1.3.5 Others
1.4 Global Carprofen Market Size Estimates and Forecasts
1.4.1 Global Carprofen Revenue 2018-2029
1.4.2 Global Carprofen Sales 2018-2029
1.4.3 Global Carprofen Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Carprofen Market Competition by Manufacturers
2.1 Global Carprofen Sales Market Share by Manufacturers (2018-2023)
2.2 Global Carprofen Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Carprofen Average Price by Manufacturers (2018-2023)
2.4 Global Carprofen Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Carprofen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carprofen, Product Type & Application
2.7 Carprofen Market Competitive Situation and Trends
2.7.1 Carprofen Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carprofen Players Market Share by Revenue
2.7.3 Global Carprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carprofen Retrospective Market Scenario by Region
3.1 Global Carprofen Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Carprofen Global Carprofen Sales by Region: 2018-2029
3.2.1 Global Carprofen Sales by Region: 2018-2023
3.2.2 Global Carprofen Sales by Region: 2024-2029
3.3 Global Carprofen Global Carprofen Revenue by Region: 2018-2029
3.3.1 Global Carprofen Revenue by Region: 2018-2023
3.3.2 Global Carprofen Revenue by Region: 2024-2029
3.4 North America Carprofen Market Facts & Figures by Country
3.4.1 North America Carprofen Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Carprofen Sales by Country (2018-2029)
3.4.3 North America Carprofen Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Carprofen Market Facts & Figures by Country
3.5.1 Europe Carprofen Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Carprofen Sales by Country (2018-2029)
3.5.3 Europe Carprofen Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carprofen Market Facts & Figures by Country
3.6.1 Asia Pacific Carprofen Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Carprofen Sales by Country (2018-2029)
3.6.3 Asia Pacific Carprofen Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Carprofen Market Facts & Figures by Country
3.7.1 Latin America Carprofen Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Carprofen Sales by Country (2018-2029)
3.7.3 Latin America Carprofen Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carprofen Market Facts & Figures by Country
3.8.1 Middle East and Africa Carprofen Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Carprofen Sales by Country (2018-2029)
3.8.3 Middle East and Africa Carprofen Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Carprofen Sales by Type (2018-2029)
4.1.1 Global Carprofen Sales by Type (2018-2023)
4.1.2 Global Carprofen Sales by Type (2024-2029)
4.1.3 Global Carprofen Sales Market Share by Type (2018-2029)
4.2 Global Carprofen Revenue by Type (2018-2029)
4.2.1 Global Carprofen Revenue by Type (2018-2023)
4.2.2 Global Carprofen Revenue by Type (2024-2029)
4.2.3 Global Carprofen Revenue Market Share by Type (2018-2029)
4.3 Global Carprofen Price by Type (2018-2029)
5 Segment by Application
5.1 Global Carprofen Sales by Application (2018-2029)
5.1.1 Global Carprofen Sales by Application (2018-2023)
5.1.2 Global Carprofen Sales by Application (2024-2029)
5.1.3 Global Carprofen Sales Market Share by Application (2018-2029)
5.2 Global Carprofen Revenue by Application (2018-2029)
5.2.1 Global Carprofen Revenue by Application (2018-2023)
5.2.2 Global Carprofen Revenue by Application (2024-2029)
5.2.3 Global Carprofen Revenue Market Share by Application (2018-2029)
5.3 Global Carprofen Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetis Carprofen Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Chanelle Pharma
6.2.1 Chanelle Pharma Corporation Information
6.2.2 Chanelle Pharma Description and Business Overview
6.2.3 Chanelle Pharma Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Chanelle Pharma Carprofen Product Portfolio
6.2.5 Chanelle Pharma Recent Developments/Updates
6.3 AVENTIX
6.3.1 AVENTIX Corporation Information
6.3.2 AVENTIX Description and Business Overview
6.3.3 AVENTIX Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AVENTIX Carprofen Product Portfolio
6.3.5 AVENTIX Recent Developments/Updates
6.4 KRKA UK Ltd
6.4.1 KRKA UK Ltd Corporation Information
6.4.2 KRKA UK Ltd Description and Business Overview
6.4.3 KRKA UK Ltd Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.4.4 KRKA UK Ltd Carprofen Product Portfolio
6.4.5 KRKA UK Ltd Recent Developments/Updates
6.5 Dechra
6.5.1 Dechra Corporation Information
6.5.2 Dechra Description and Business Overview
6.5.3 Dechra Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dechra Carprofen Product Portfolio
6.5.5 Dechra Recent Developments/Updates
6.6 Parnell
6.6.1 Parnell Corporation Information
6.6.2 Parnell Description and Business Overview
6.6.3 Parnell Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Parnell Carprofen Product Portfolio
6.6.5 Parnell Recent Developments/Updates
6.7 VetUK
6.6.1 VetUK Corporation Information
6.6.2 VetUK Description and Business Overview
6.6.3 VetUK Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.4.4 VetUK Carprofen Product Portfolio
6.7.5 VetUK Recent Developments/Updates
6.8 Norbrook
6.8.1 Norbrook Corporation Information
6.8.2 Norbrook Description and Business Overview
6.8.3 Norbrook Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Norbrook Carprofen Product Portfolio
6.8.5 Norbrook Recent Developments/Updates
6.9 Alivira Animal Health
6.9.1 Alivira Animal Health Corporation Information
6.9.2 Alivira Animal Health Description and Business Overview
6.9.3 Alivira Animal Health Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Alivira Animal Health Carprofen Product Portfolio
6.9.5 Alivira Animal Health Recent Developments/Updates
6.10 Vedco Inc
6.10.1 Vedco Inc Corporation Information
6.10.2 Vedco Inc Description and Business Overview
6.10.3 Vedco Inc Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Vedco Inc Carprofen Product Portfolio
6.10.5 Vedco Inc Recent Developments/Updates
6.11 ElancoDVM
6.11.1 ElancoDVM Corporation Information
6.11.2 ElancoDVM Carprofen Description and Business Overview
6.11.3 ElancoDVM Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ElancoDVM Carprofen Product Portfolio
6.11.5 ElancoDVM Recent Developments/Updates
6.12 Vethical
6.12.1 Vethical Corporation Information
6.12.2 Vethical Carprofen Description and Business Overview
6.12.3 Vethical Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Vethical Carprofen Product Portfolio
6.12.5 Vethical Recent Developments/Updates
6.13 Vetoquinol
6.13.1 Vetoquinol Corporation Information
6.13.2 Vetoquinol Carprofen Description and Business Overview
6.13.3 Vetoquinol Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Vetoquinol Carprofen Product Portfolio
6.13.5 Vetoquinol Recent Developments/Updates
6.14 Pivetal
6.14.1 Pivetal Corporation Information
6.14.2 Pivetal Carprofen Description and Business Overview
6.14.3 Pivetal Carprofen Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Pivetal Carprofen Product Portfolio
6.14.5 Pivetal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carprofen Industry Chain Analysis
7.2 Carprofen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carprofen Production Mode & Process
7.4 Carprofen Sales and Marketing
7.4.1 Carprofen Sales Channels
7.4.2 Carprofen Distributors
7.5 Carprofen Customers
8 Carprofen Market Dynamics
8.1 Carprofen Industry Trends
8.2 Carprofen Market Drivers
8.3 Carprofen Market Challenges
8.4 Carprofen Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
